Page last updated: 2024-09-05

sorafenib and alprostadil

sorafenib has been researched along with alprostadil in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(alprostadil)
Trials
(alprostadil)
Recent Studies (post-2010) (alprostadil)
6,5207305,2517,136864761

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)alprostadil (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)2.3
Solute carrier organic anion transporter family member 2B1Rattus norvegicus (Norway rat)0.0358

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hussar, DA1
Bito, T; Hirai, M; Hirano, T; Ishida, T; Nakagawa, T; Nishigori, C; Shichiri, H; Tokura, M; Uda, A; Yamamoto, K; Yano, I1

Other Studies

2 other study(ies) available for sorafenib and alprostadil

ArticleYear
New drugs 07, part I.
    Nursing, 2007, Volume: 37, Issue:2

    Topics: Abatacept; Acetanilides; Alprostadil; Anidulafungin; Antidiuretic Hormone Receptor Antagonists; Antifungal Agents; Antineoplastic Agents; Arabinonucleosides; Benzazepines; Benzenesulfonates; Drug Approval; Drug Interactions; Drug Monitoring; Drug Therapy; Echinocandins; Fatty Acids; Humans; Hypoglycemic Agents; Immunoconjugates; Immunosuppressive Agents; Indoles; Insulin; Insulin Detemir; Insulin, Long-Acting; Intercellular Signaling Peptides and Proteins; Lenalidomide; Lubiprostone; Niacinamide; Patient Education as Topic; Peptides, Cyclic; Phenylurea Compounds; Piperazines; Pyridines; Pyrroles; Ranolazine; Sorafenib; Sunitinib; Thalidomide; United States

2007
Prostaglandin E
    Biochemical and biophysical research communications, 2017, 04-01, Volume: 485, Issue:2

    Topics: Alprostadil; Antineoplastic Agents; Cell Line; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Hand-Foot Syndrome; Humans; Keratinocytes; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Skin; Sorafenib; STAT3 Transcription Factor

2017